Meeting Report of the Fifth International Cancer Epigenetics Conference in Beijing, China, October 2016
-
- Dan Gao
- Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing100853, China
-
- James G Herman
- Department of Medicine, University of Pittsburgh School of Medicine, Pittsburg, PA 15232, USA
-
- Hengmi Cui
- Institute of Epigenetics & Epigenomics, Yangzhou University, Yangzhou225000, China
-
- Jin Jen
- Department of Laboratory of Medicine & Pathology, Mayo Clinic, Rochester, MN 55905, USA
-
- Francois Fuks
- Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels1070, Belgium
-
- Malcolm V Brock
- Oncology Center, Johns Hopkins University, Baltimore, MD 21231, USA
-
- Toshikazu Ushijima
- Division of Epigenomics, National Cancer Center Research Institute, Tokyo104-0045, Japan
-
- Carlo Croce
- Department of Cancer Biology & Genetics, College of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA
-
- Yoshimitsu Akiyama
- Department of Molecular Oncology, Graduate School of Medical & Dental Sciences, Tokyo Medical & Dental University, Tokyo113-8519, Japan
-
- Mingzhou Guo
- Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing100853, China
説明
Fifth International Cancer Epigenetics Conference, Beijing, China, 21-23 October 2016 This meeting reported many new findings in the field of cancer epigenetics, including basic science, translational and clinical studies. In this report, we summarize some of the main advancements and prospects in cancer epigenetics presented at this meeting.
収録刊行物
-
- Epigenomics
-
Epigenomics 9 (7), 937-941, 2017-05-22
Informa UK Limited
